US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 40.270
  • +0.680+1.72%
Close Dec 24 13:00 ET
  • 40.200
  • -0.070-0.17%
Post 17:01 ET
15.50BMarket Cap-6.93P/E (TTM)

About Moderna Company

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5600
Fiscal Year Ends12-31
Address325 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-714-6500
Websitehttp://www.modernatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephane Bancel
  • Director and Chief Executive Officer
  • 17.07M
  • Shannon Thyme Klinger
  • Chief Legal Officer and Corporate Secretary
  • 4.31M
  • Jerh Collins
  • Chief Technical Operations and Quality Officer
  • --
  • Tracey Franklin
  • Chief Human Resources Officer
  • --
  • Brad Miller
  • Chief Information Officer
  • --
  • James M Mock
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Kate Cronin
  • Chief Brand Officer
  • --
  • Dr. Stephen Hoge, M.D.
  • President
  • 7.34M
  • Dr. Noubar B. Afeyan, PhD
  • Chairman of the Board
  • 663.52K
  • Abbas Hussain
  • Director
  • --
  • David M. Rubenstein
  • Director
  • --
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 481.27K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 476.25K
  • Elizabeth E. Tallett
  • Independent Director
  • 481.27K
  • Paul Sagan
  • Independent Director
  • 461.27K
  • Dr. Francois Nader, M.D.
  • Independent Director
  • 481.27K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+1.41%
Workday
WDAY
+1.38%
Dorian LPG
LPG
+1.12%
DexCom
DXCM
+0.88%
Precision Drilling
PDS
+0.86%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.22%